Ottavia Bernocchi
Cremona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
Journal: Therapeutic advances in medical oncology
Published: April 10, 2023
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 31, 2023
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
Journal: NPJ breast cancer
Published: December 16, 2022
Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.
Journal: Oncotarget
Published: December 06, 2022
Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134-152].
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 28, 2021
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.
Journal: Frontiers in oncology
Published: March 27, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2020
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer.
Journal: Frontiers in cell and developmental biology
Published: December 14, 2020
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 11, 2020
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 11, 2020
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: September 24, 2020
Last Updated: 09/26/2026